Cost-effectiveness of lumbar artificial intervertebral disc replacement: driven by the choice of comparator

Background Lower back pain is a common and costly condition in Australia. This paper aims to conduct an economic evaluation of lumbar artificial intervertebral disc replacement (AIDR) compared with lumbar fusion for the treatment of patients suffering from significant axial back pain and/or radicula...

Full description

Saved in:
Bibliographic Details
Published inANZ journal of surgery Vol. 83; no. 9; pp. 669 - 675
Main Authors Parkinson, Bonny, Goodall, Stephen, Thavaneswaran, Prema
Format Journal Article
LanguageEnglish
Published Australia Blackwell Publishing Ltd 01.09.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Lower back pain is a common and costly condition in Australia. This paper aims to conduct an economic evaluation of lumbar artificial intervertebral disc replacement (AIDR) compared with lumbar fusion for the treatment of patients suffering from significant axial back pain and/or radicular (nerve root) pain, secondary to disc degeneration or prolapse, who have failed conservative treatment. Methods A cost‐effectiveness approach was used to compare costs and benefits of AIDR to five fusion approaches. Resource use was based on Medicare Benefits Schedule claims data and expert opinion. Effectiveness and re‐operation rates were based on published randomized controlled trials. The key clinical outcomes considered were narcotic medication discontinuation, achievement of overall clinical success, achievement of Oswestry Disability Index success and quality‐adjusted life‐years gained. Results AIDR was estimated to be cost‐saving compared with fusion overall ($1600/patient); however, anterior lumbar interbody fusion and posterolateral fusion were less costly by $2155 and $807, respectively. The incremental cost‐effectiveness depends on the outcome considered and the comparator. Conclusions AIDR is potentially a cost‐saving treatment for lumbar disc degeneration, although longer‐term follow‐up data are required to substantiate this claim. The incremental cost‐effectiveness depends on the outcome considered and the comparator, and further research is required before any firm conclusions can be drawn.
Bibliography:istex:087BC151E836C84F8F8D8B8E0064BE2E13B45A30
ArticleID:ANS12009
ark:/67375/WNG-0BQLQ18D-J
ANZ Journal of Surgery, v.83, no.9, Sept 2013: (669)-675
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1445-1433
1445-2197
DOI:10.1111/ans.12009